Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2026-01-08 @ 8:46 PM
Study NCT ID:
NCT00809250
Status:
COMPLETED
Last Update Posted:
2020-09-16
First Post:
2008-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-15
First Submit QC Date:
None
Study First Post Date:
2008-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-15
Last Update Post Date:
2020-09-16
Last Update Post Date Type:
ACTUAL